Latest market price
34.81
+0.45+1.30%
URGNQT64UroGen Pharma Ltd.·NASDAQ
34.81+1.30%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 09, 20264Statement of changes in beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Aug 28, 20264Statement of changes in beneficial ownership
Aug 24, 20264Statement of changes in beneficial ownership
Aug 20, 20268-KCurrent report
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 05, 20268-KCurrent report
Aug 05, 202610-QQuarterly report
Jul 10, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
Jun 09, 20264Statement of changes in beneficial ownership
Jun 02, 20268-KCurrent report
May 27, 20264Statement of changes in beneficial ownership
May 27, 2026ARSAnnual report to shareholders
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)